Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.

Down syndrome (DS) children have a high frequency of acute megakaryoblastic leukemia (AMKL) in early childhood. At least 2 in utero genetic events are required, although not sufficient, for DS-AMKL: trisomy 21 (T21) and N-terminal-truncating GATA1 mutations. To investigate the role of T21 in DS-AMKL, we compared second trimester hemopoiesis in DS without GATA1 mutations to gestation-matched normal controls. In all DS fetal livers (FLs), but not marrows, megakaryocyte-erythroid progenitor frequency was increased (55.9% +/- 4% vs 17.1% +/- 3%, CD34(+)CD38(+) cells; P < .001) with common myeloid progenitors (19.6% +/- 2% vs 44.0% +/- 7%) and granulocyte-monocyte (GM) progenitors (15.8% +/- 4% vs 34.5% +/- 9%) commensurately reduced. Clonogenicity of DS-FL versus normal FL CD34(+) cells was markedly increased (78% +/- 7% vs 15% +/- 3%) affecting megakaryocyte-erythroid ( approximately 7-fold higher) and GM and colony-forming unit-granulocyte, erythrocyte macrophage, megakaryocyte (CFU-GEMM) progenitors. Replating efficiency of CFU-GEMM was also markedly increased. These data indicate that T21 itself profoundly disturbs FL hemopoiesis and they provide a testable hypothesis to explain the increased susceptibility to GATA1 mutations in DS-AMKL and DS-associated transient myeloproliferative disorder.

[1]  P. Vyas,et al.  Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML , 2008, Leukemia.

[2]  Sharon R. Pine,et al.  Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. , 2007, Blood.

[3]  R. Christensen,et al.  Hematological abnormalities during the first week of life among neonates with Down syndrome: Data from a multihospital healthcare system , 2007, American journal of medical genetics. Part A.

[4]  A. F. Cunha,et al.  An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis , 2006, Nature Genetics.

[5]  John J Doyle,et al.  A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. , 2006, Blood.

[6]  S. Winter,et al.  Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder. , 2006, The Journal of pediatrics.

[7]  R. Reeves,et al.  Understanding the Basis for Down Syndrome Phenotypes , 2006, PLoS genetics.

[8]  Aravind Subramanian,et al.  Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Péault,et al.  The changing cellular environments of hematopoiesis in human development in utero. , 2005, Experimental hematology.

[10]  B. Göttgens,et al.  The proto-oncogene ERG in megakaryoblastic leukemias. , 2005, Cancer research.

[11]  S. Orkin,et al.  Developmental stage–selective effect of somatically mutated leukemogenic transcription factor GATA1 , 2005, Nature Genetics.

[12]  P. Vyas,et al.  GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder , 2005, British journal of haematology.

[13]  J. Horan.  Myelodysplastic and Myeloproliferative Disorders in Children , 2004 .

[14]  A. Zipursky,et al.  Distinct gene signatures of transient and acute megakaryoblastic leukemia in Down syndrome , 2004, Leukemia.

[15]  J. Taub,et al.  Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome. , 2004, Blood.

[16]  P. Vyas,et al.  Natural history of GATA1 mutations in Down syndrome. , 2004, Blood.

[17]  Y. Hayashi,et al.  Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome. , 2003, Blood.

[18]  A. Teigler‐Schlegel,et al.  Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. , 2003, Blood.

[19]  S. Scherer,et al.  GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. , 2003, Blood.

[20]  R. Arceci,et al.  Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis. , 2003, Blood.

[21]  Kazuhiro Ishii,et al.  [Down syndrome]. , 2003, Ryoikibetsu shokogun shirizu.

[22]  M. L. Beau,et al.  Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome , 2002, Nature Genetics.

[23]  N. Fisk,et al.  Circulating hematopoietic progenitor cells in first trimester fetal blood. , 2000, Blood.

[24]  J. Buckley,et al.  Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891. , 1998, Blood.

[25]  J. Downing,et al.  AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.